STOCK TITAN

Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Alpine Immune Sciences, Inc. (ALPN) will release its fourth quarter and full year 2023 financial results on March 18, 2024. The company focuses on developing treatments for autoimmune and inflammatory diseases. A conference call and webcast will be held on the same day.
Positive
  • None.
Negative
  • None.

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced the Company will release fourth quarter and full year 2023 financial results on Monday, March 18, 2024, after the close of market. The Company will host a corresponding conference call and live webcast at 4:30 p.m. ET/1:30 p.m. PT on the same day.

Conference Call and Webcast Information

The link to the webcast will be available in the investor relations section of the Company’s website at https://ir.alpineimmunesciences.com/events and a replay will be available on the Company's website for 90 days following the live event.

About Alpine Immune Sciences

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on X and LinkedIn.

Media and Investor Relations Contacts:

ir@alpineimmunesciences.com

media@alpineimmunesciences.com

Source: Alpine Immune Sciences, Inc.

FAQ

When will Alpine Immune Sciences release its fourth quarter and full year 2023 financial results?

Alpine Immune Sciences will release its fourth quarter and full year 2023 financial results on Monday, March 18, 2024.

What is Alpine Immune Sciences' ticker symbol?

The ticker symbol for Alpine Immune Sciences is ALPN.

What does Alpine Immune Sciences focus on developing?

Alpine Immune Sciences focuses on developing innovative treatments for autoimmune and inflammatory diseases.

When will the conference call and webcast be held?

The conference call and live webcast will be held at 4:30 p.m. ET/1:30 p.m. PT on Monday, March 18, 2024.

Where can the webcast link be found?

The webcast link will be available in the investor relations section of Alpine Immune Sciences' website at https://ir.alpineimmunesciences.com/events.

Alpine Immune Sciences, Inc.

NASDAQ:ALPN

ALPN Rankings

ALPN Latest News

ALPN Stock Data

4.46B
44.92M
4.64%
91.41%
8.06%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
SEATTLE

About ALPN

founded in 2015 by a team responsible for the fda's approval of the world's first cancer immunotherapy and experts in the field of recombinant protein based immunotherapies, alpine immune sciences was created to capitalize on our unique understanding of immunology, modifying the complexities of the immune synapse for the benefit of patients living with cancer, autoimmune disorders, and other diseases. traded on nasdaq under ticker alpn.